Sort
82,697 grants matching “vaccine development”
Molecular Biology of Francisella tularensis Virulence
$1,655,093Michael V Norgard · Ut Southwestern Medical Center · P01 · FY2007 · AI
Exploring the impact of inflammaging on immune function during M. tb infection
$1,654,552Joanne Turner · Texas Biomedical Research Institute · P01 · FY2020 · AG
Vanderbilt HIV Clinical Trials Unit
$1,654,259Richard T D'aquila · Vanderbilt University · U01 · FY2007 · AI
Genes for Tolerance and Immunity Consortium
$1,653,757Australian National University · R01 · FY2004 · AI
SPECIFIC PATHOGEN FREE RHESUS MACAQUE BREEDING PROGRAM
$1,652,724Alpha Genesis, Inc. · U01 · FY2002 · AI
Host Immunity Against Bacteria
$1,652,722Ian Myles · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
The MW Cancer Prevention Clinical Trials Network
$1,652,564Howard H Bailey · University Of Wisconsin-Madison · UG1 · FY2022 · CA
Centers for AIDS Research (CFAR)
$1,652,403Kent J. Weinhold · Duke University · P30 · FY2015 · AI
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,652,241Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Development/production of universal influenza vaccines
$1,652,145Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2021 · AI
Host Genetics Core
$1,651,833Norman L Letvin · Duke University · U19 · FY2010 · AI
Directing Tumor-specific T cells to Tumors
$1,651,765Pawel Kalinski · University Of Pittsburgh At Pittsburgh · P01 · FY2012 · CA
Molecular Analysis of Tuberculosis Immunity
$1,651,620William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2013 · AI
The origin, predictors, and immune correlates of viral rebound in orally SHIV infected infant monkeys
$1,651,483Sallie R. Permar · Duke University · P01 · FY2018 · AI
UAB Center for AIDS Research
$1,651,248University Of Alabama At Birmingham · P30 · FY2004 · AI
Development of Technologies to Facilitate the use and Response of Vaccines
$1,651,037Marc Joseph Gurwith · Paxvax, Inc. · N01 · FY2012 · AI
Malaria Drug Resistance and Disease Virulence
$1,650,826Thomas E Wellems · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
CORE NICHD NETWORK CLINICAL SITE SUPPORT FOR IMPAACT RELATED STUDIES
$1,650,681Barbara Driver · Westat, Inc. · N01 · FY2020 · HD
SAN FRANCISCO HIV VACCINE CLINICAL TRAILS UNIT
$1,650,506Public Health Foundation Enterprises · U01 · FY2005 · AI
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
$1,650,200Benjamin Doranz · Integral Molecular · N01 · FY2013 · AI
CNH-L: Dynamics of Zoonotic Systems: Human-Bat-Pathogen Interactions
$1,650,000Raina K Plowright · Montana State University · · FY2017 · BIO
HIV LCMV vaccines
$1,650,000Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2009 · AI
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$1,649,808Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Dry Season Ecology of Malaria Vectors
$1,649,772Tovi Lehmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Research Project 2: Antigen design and immunological evaluation
$1,649,403Steven Bradfute · Albert Einstein College Of Medicine · U19 · FY2025 · AI